Hipp A A, Heitkamp H C, Röcker K, Dickhuth H H
Medical Clinic, Department of Sports Medicine, University of Tübingen, Silcherstrasse 5, 72076 Tübingen, Germany.
Int J Sports Med. 2004 Jan;25(1):20-6. doi: 10.1055/s-2003-45227.
Hypertrophic cardiomyopathy (HCM) is one of the primary causes of sudden cardiac death in athletes < 35 years of age. The highest risk of sudden cardiac death is associated with syncope, early age, extreme ventricular hypertrophy, ventricular tachycardia, and a family history of sudden death. The relative risk in competitive sports is unknown. Usually, sports eligibility is rejected. However, some athletes with HCM tolerate extreme athletic lifestyles without complications. Sports-related aspects of diagnosis, therapy, and sports eligibility are presented, and discussed. Two case reports are presented: a 20-year-old professional soccer player and a 66-year-old long-distance runner. Athletes with HCM should not participate in most competitive sports with the possible exception of those of low dynamic and low static intensity. Participation in low to moderate athletic activities may be allowed in selected patients without risk factors and > 35 years of age.
肥厚型心肌病(HCM)是35岁以下运动员心源性猝死的主要原因之一。心源性猝死的最高风险与晕厥、年龄较小、极度心室肥厚、室性心动过速以及猝死家族史有关。竞技运动中的相对风险尚不清楚。通常,体育参赛资格会被拒绝。然而,一些患有HCM的运动员能够耐受极端的运动生活方式而无并发症。本文介绍并讨论了与运动相关的诊断、治疗及体育参赛资格等方面内容。还给出了两个病例报告:一名20岁的职业足球运动员和一名66岁的长跑运动员。患有HCM的运动员不应参加大多数竞技运动,低动态和低静态强度的运动可能除外。对于无危险因素且年龄大于35岁的特定患者,可允许其参加低至中等强度的体育活动。